Home » Newsletters » BioWorld Asia

BioWorld Asia

April 19, 2000

View Archived Issues

Mergers, Alliances Help Improve Bottom Lines Of European Sector

Rat Study Shows Brain Stem Cells Could Deliver Therapies

European Parliament Votes For Tighter Restrictions On GMOs

Genset, Sanofi-Synthilabo Enter Pharmacogenomics Collaboration

Atugen Enters Target Validation Deal With Boehringer Ingelheim

Other News To Note

Founder Populations Elucidate Genetics Of Complex Disorders

Australian Center Opens To Make Chirally Pure Compounds

British Biotech Forms Alliance To Gets Access To U.S. Data

Geron Official Says UK Ban On Cloning Hinders Research

L'Orial Adopts Chemunex D-Scan Microbial Analyzer

Medigene Acquires Novel 'In Vitro Heart' Technology

Synt:em Confirms Potential Of Pep:trans Drug Delivery Method

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...